Theranos Adds SEC Investigation to Blood Test Scrutiny

Theranos Inc. disclosed that it is under investigation by the U.S. Securities and Exchange Committee following scrutiny of its blood tests from federal and state health regulators. Bloomberg's Sheelah Kolhatkar explains how the investigation could impact the company's business on "Bloomberg Markets." (Source: Bloomberg)

Infosys CEO Resigns After Criticism From Founders
04:36 - Infosys Ltd. Chief Executive Officer Vishal Sikka has stepped down following criticism from the company’s founder. Chief Operating Officer Pravin Rao will become interim CEO. Bloomberg's Caroline Hyde reports on "Bloomberg Technology." (Source: Bloomberg)
  • Essential's 360 Degree Approach to Smartphones
  • Why Industrial Metals May Be in a Bull Market
  • Who Moved the Most on Bloomberg's Billionaire Index 8/18